Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024
24 avr. 2024 22h11 HE
|
Association québécoise des technologies (AQT)
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024Charlevoix (Québec), le 24 avril 2024 – C’est avec fierté que l’AQT
Global Vaccine Adjuvants Market Size To Worth USD 1.51 Billion By 2033 | CAGR of 3.9%
17 avr. 2024 08h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , April 17, 2024 (GLOBE NEWSWIRE) -- The Global Vaccine Adjuvants Market Size is to Grow from USD 1.03 Billion in 2023 to USD 1.51 Billion by 2033, at a Compound Annual...
Bion Announces Voluntary Share Surrender
02 avr. 2024 08h34 HE
|
BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, April 02, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock waste treatment technology and premium sustainable beef,...
MannKind Announces CFO Transition
26 mars 2024 16h05 HE
|
MannKind
MANNKIND ANNOUNCES CFO TRANSITION
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
26 mars 2024 02h00 HE
|
VALNEVA
Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the ...
Bion Applies for OMRI Listing for Commercial 10-0-0 Nitrogen Fertilizer
12 mars 2024 10h44 HE
|
BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, March 12, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a developer of advanced livestock waste treatment and resource recovery technology, announced...
Vaccine Adjuvants Market to Reach $1.5Billion Globally, By 2032 at 4% CAGR: Allied Market Research
12 mars 2024 09h02 HE
|
Allied Analytics LLP
Wilmington, New Castle, Delaware, March 12, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Vaccine Adjuvants Market by Product Type (Immunostimulants and Vehicles...
Global Recombinant Vaccine Market Size To Exceed USD 24.9 Billion By 2032 | CAGR of 11.75%
11 mars 2024 06h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States, March 11, 2024 (GLOBE NEWSWIRE) -- The Global Recombinant Vaccine Market Size is to Grow from USD 8.2 Billion in 2022 to USD 24.9 Billion by 2032, at a Compound Annual...
SoftServe Achieves AWS Generative AI Competency as Inaugural Launch Partner
07 mars 2024 08h35 HE
|
SoftServe
AUSTIN, Texas, March 07, 2024 (GLOBE NEWSWIRE) -- SoftServe, a premier IT consulting and digital services provider, today announced that it has become an inaugural partner to obtain the Amazon Web...
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination
06 mars 2024 15h30 HE
|
ACTG
ACTG at CROI: HepB-CPG Vaccine Outperforms Standard Hepatitis B Vaccine for HIV Patients with Previous Vaccination Failures